Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Xtant Medical Holdings (XTNT) Net Cash Flow (2016 - 2025)

Xtant Medical Holdings (XTNT) has disclosed Net Cash Flow for 16 consecutive years, with $3.5 million as the latest value for Q3 2025.

  • Quarterly Net Cash Flow rose 121.8% to $3.5 million in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $3.6 million through Sep 2025, up 311.82% year-over-year, with the annual reading at $447000.0 for FY2024, 103.06% up from the prior year.
  • Net Cash Flow for Q3 2025 was $3.5 million at Xtant Medical Holdings, up from $1.6 million in the prior quarter.
  • The five-year high for Net Cash Flow was $16.3 million in Q1 2021, with the low at -$15.1 million in Q1 2023.
  • Average Net Cash Flow over 5 years is $440105.3, with a median of -$124000.0 recorded in 2022.
  • The sharpest move saw Net Cash Flow soared 1379.3% in 2022, then tumbled 966.17% in 2023.
  • Over 5 years, Net Cash Flow stood at -$227000.0 in 2021, then skyrocketed by 1379.3% to $2.9 million in 2022, then crashed by 199.97% to -$2.9 million in 2023, then soared by 73.96% to -$756000.0 in 2024, then skyrocketed by 565.61% to $3.5 million in 2025.
  • According to Business Quant data, Net Cash Flow over the past three periods came in at $3.5 million, $1.6 million, and -$784000.0 for Q3 2025, Q2 2025, and Q1 2025 respectively.